{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:34:51Z","timestamp":1791981291356,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National College Students Innovation Training Program of Henan Province","award":["202310472003"],"award-info":[{"award-number":["202310472003"]}]},{"name":"the Young Talents Project Foundation from Science and Technology Department of Jiangxi Province","award":["20204BCJ23020"],"award-info":[{"award-number":["20204BCJ23020"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960015"],"award-info":[{"award-number":["81960015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypoxic pulmonary hypertension (HPH) is a challenging lung arterial disorder with remarkably high incidence and mortality rates, and the efficiency of current HPH treatment strategies is unsatisfactory. Endothelial-to-mesenchymal transition (EndMT) in the pulmonary artery plays a crucial role in HPH. Previous studies have shown that lncRNA-H19 (H19) is involved in many cardiovascular diseases by regulating cell proliferation and differentiation but the role of H19 in EndMT in HPH has not been defined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this research, the expression of H19 was investigated in PAH human patients and rat models. Then, we established a hypoxia-induced HPH rat model to evaluate H19 function in HPH by Echocardiography and hemodynamic measurements. Moreover, luciferase reporter gene detection, and western blotting were used to explore the mechanism of H19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, we first found that the expression of H19 was significantly increased in the endodermis of pulmonary arteries and that H19 deficiency obviously ameliorated pulmonary vascular remodelling and right heart failure in HPH rats, and these effects were associated with inhibition of EndMT. Moreover, an analysis of luciferase activity indicated that microRNA-let-7\u00a0g (let-7\u00a0g) was a direct target of H19. H19 deficiency or let-7\u00a0g overexpression can markedly downregulate the expression of TGF\u03b2R1, a novel target gene of let-7\u00a0g. Furthermore, inhibition of TGF\u03b2R1 induced similar effects to H19 deficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In summary, our findings demonstrate that the H19\/let-7\u00a0g\/TGF\u03b2R1 axis is crucial in the pathogenesis of HPH by stimulating EndMT. Our study may provide new ideas for further research on HPH therapy in the near future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-024-02895-y","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T18:01:52Z","timestamp":1720634512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["LncRNAH19 acts as a ceRNA of let-7\u00a0g to facilitate endothelial-to-mesenchymal transition in hypoxic pulmonary hypertension via regulating TGF-\u03b2 signalling pathway"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-1395","authenticated-orcid":false,"given":"Weifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"4","key":"2895_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00408-020-00375-w","volume":"198","author":"ZGS Vazquez","year":"2020","unstructured":"Vazquez ZGS, Klinger JR. Guidelines for the treatment of pulmonary arterial hypertension. Lung. 2020;198(4):581\u201396.","journal-title":"Lung"},{"issue":"2","key":"2895_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/biom12020265","volume":"12","author":"CL Welch","year":"2022","unstructured":"Welch CL, Chung WK. Channelopathy genes in pulmonary arterial hypertension. Biomolecules. 2022;12(2):265.","journal-title":"Biomolecules"},{"key":"2895_CR3","doi-asserted-by":"crossref","unstructured":"Ruaro B, Baratella E, Caforio G, Confalonieri P, Wade B, Marrocchio C, Geri P, Pozzan R, Andrisano AG, Cova MA, Cortale M, Confalonieri M, Salton F. Chronic thromboembolic pulmonary hypertension: an update. Diagnostics (Basel). 2022;12(2).","DOI":"10.3390\/diagnostics12020235"},{"key":"2895_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2022.02.003","volume":"212","author":"A Tzoumas","year":"2022","unstructured":"Tzoumas A, Peppas S, Sagris M, Papanastasiou CA, Barakakis PA, Bakoyiannis C, Taleb A, Kokkinidis DG, Giannakoulas G. Advances in treatment of chronic thromboembolic pulmonary hypertension. Thromb Res. 2022;212:30\u20137.","journal-title":"Thromb Res"},{"issue":"9","key":"2895_CR5","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.mayocp.2020.04.039","volume":"95","author":"SA Mandras","year":"2020","unstructured":"Mandras SA, Mehta HS, Vaidya A. Pulmonary hypertension: a brief guide for clinicians. Mayo Clin Proc. 2020;95(9):1978\u201388.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"2895_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1183\/09031936.00078411","volume":"39","author":"J Hurdman","year":"2012","unstructured":"Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, Billings C, Lawrie A, Sabroe I, Akil M, O\u2019Toole L, Kiely DG. ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a REferral centre. Eur Respir J. 2012;39(4):945\u201355.","journal-title":"Eur Respir J"},{"key":"2895_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2016.11.020","volume":"170","author":"WF Zhang","year":"2017","unstructured":"Zhang WF, Xiong YW, Zhu TT, Xiong AZ, Bao HH, Cheng XS. MicroRNA let-7\u00a0g inhibited hypoxia-induced proliferation of PASMCs via G(0)\/G(1) cell cycle arrest by targeting c-myc. Life Sci. 2017;170:9\u201315.","journal-title":"Life Sci"},{"issue":"2","key":"2895_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/FJC.0000000000001156","volume":"79","author":"T Zhu","year":"2022","unstructured":"Zhu T, Wang X, Zheng Z, Quan J, Liu Y, Wang Y, Liu T, Liu X, Wang M, Zhang Z. ZIP12 contributes to hypoxic pulmonary hypertension by driving phenotypic switching of pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol. 2022;79(2):235\u201343.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"2895_CR9","first-page":"141","volume":"1","author":"KR Stenmark","year":"2011","unstructured":"Stenmark KR, Nozik-Grayck E, Gerasimovskaya E, Anwar A, Li M, Riddle S, Frid M. The adventitia: essential role in pulmonary vascular remodeling. Compr Physiol. 2011;1(1):141\u201361.","journal-title":"Compr Physiol"},{"issue":"2","key":"2895_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1159\/000495331","volume":"51","author":"L Zhang","year":"2018","unstructured":"Zhang L, Li YM, Zeng XX, Wang XY, Chen SK, Gui LX, Lin MJ. Galectin-3- mediated transdifferentiation of pulmonary artery endothelial cells contributes to hypoxic pulmonary vascular remodeling. Cell Physiol Biochem. 2018;51(2):763\u201377.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"2895_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","volume":"131","author":"B Ranchoux","year":"2015","unstructured":"Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Pechoux C, Bogaard HJ, Dorfmuller P, Remy S, Lecerf F, Plante S, Chat S, Fadel E, Houssaini A, Anegon I, Adnot S, Simonneau G, Humbert M, Cohen-Kaminsky S, Perros F. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation. 2015;131(11):1006\u201318.","journal-title":"Circulation"},{"key":"2895_CR12","doi-asserted-by":"publisher","first-page":"862017","DOI":"10.3389\/fphar.2022.862017","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, He Y, Yu Z, Zuo J, Huang Y, Ruan Y, Zheng X, Ma Y. Polydatin glycosides improve monocrotaline-induced pulmonary hypertension injury by inhibiting endothelial-to-mesenchymal transition. Front Pharmacol. 2022;13:862017.","journal-title":"Front Pharmacol"},{"issue":"13","key":"2895_CR13","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491\u2013509.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2895_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12964-020-00654-2","volume":"18","author":"W Gui","year":"2020","unstructured":"Gui W, Zhu WF, Zhu Y, Tang S, Zheng F, Yin X, Lin X, Li H. LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1. Cell Commun Signal. 2020;18(1):173.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"2895_CR15","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1096\/fj.202000073RRRRR","volume":"34","author":"T Cao","year":"2020","unstructured":"Cao T, Jiang Y, Li D, Sun X, Zhang Y, Qin L, Tellides G, Taylor HS, Huang Y. H19\/TET1 axis promotes TGF-beta signaling linked to endothelial-to-mesenchymal transition. FASEB J. 2020;34(6):8625\u201340.","journal-title":"FASEB J"},{"key":"2895_CR16","doi-asserted-by":"publisher","first-page":"770163","DOI":"10.3389\/fcvm.2021.770163","volume":"8","author":"SF Huang","year":"2021","unstructured":"Huang SF, Zhao G, Peng XF, Ye WC. The pathogenic role of long non-coding RNA H19 in atherosclerosis via the miR-146a-5p\/ANGPTL4 pathway. Front Cardiovasc Med. 2021;8:770163.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2895_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13578-021-00668-4","volume":"11","author":"W Su","year":"2021","unstructured":"Su W, Huo Q, Wu H, Wang L, Ding X, Liang L, Zhou L, Zhao Y, Dan J, Zhang H. The function of LncRNA-H19 in cardiac hypertrophy. Cell Biosci. 2021;11(1):153.","journal-title":"Cell Biosci"},{"issue":"15","key":"2895_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1161\/CIRCULATIONAHA.120.047626","volume":"142","author":"J Omura","year":"2020","unstructured":"Omura J, Habbout K, Shimauchi T, Wu WH, Breuils-Bonnet S, Tremblay E, Martineau S, Nadeau V, Gagnon K, Mazoyer F, Perron J, Potus F, Lin JH, Zafar H, Kiely DG, Lawrie A, Archer SL, Paulin R, Provencher S, Boucherat O, Bonnet S. Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension. Circulation. 2020;142(15):1464\u201384.","journal-title":"Circulation"},{"key":"2895_CR19","doi-asserted-by":"publisher","first-page":"868918","DOI":"10.3389\/fcell.2022.868918","volume":"10","author":"D Wang","year":"2022","unstructured":"Wang D, Ao J, Xiong Y, Zhang X, Zhang W. Systematic analysis of stress granule regulators-associated molecular subtypes predicts drug response, immune response, and prognosis in non-small cell lung cancer. Front Cell Dev Biol. 2022;10:868918.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2895_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1378\/chest.11-0449","volume":"141","author":"M Mura","year":"2012","unstructured":"Mura M, Anraku M, Yun Z, McRae K, Liu M, Waddell TK, Singer LG, Granton JT, Keshavjee S, de Perrot M. Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis. Chest. 2012;141(3):661\u201373.","journal-title":"Chest"},{"issue":"11","key":"2895_CR21","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/resp.13557","volume":"24","author":"M Mura","year":"2019","unstructured":"Mura M, Cecchini MJ, Joseph M, Granton JT. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension. Respirology. 2019;24(11):1104\u201310.","journal-title":"Respirology"},{"issue":"6","key":"2895_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1165\/rcmb.2018-0368OC","volume":"60","author":"RS Stearman","year":"2019","unstructured":"Stearman RS, Bui QM, Speyer G, Handen A, Cornelius AR, Graham BB, Kim S, Mickler EA, Tuder RM, Chan SY, Geraci MW. Systems analysis of the human pulmonary arterial hypertension lung transcriptome. Am J Respir Cell Mol Biol. 2019;60(6):637\u201349.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"2895_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bbrc.2017.01.073","volume":"488","author":"WF Zhang","year":"2017","unstructured":"Zhang WF, Zhu TT, Xiong YW, Xiong AZ, Ge XY, Hu CP, Zhang Z. Negative feedback regulation between microRNA let-7\u00a0g and LOX-1 mediated hypoxia-induced PASMCs proliferation. Biochem Biophys Res Commun. 2017;488(4):655\u201363.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2895_CR24","first-page":"1294","volume":"32","author":"WF Zhang","year":"2016","unstructured":"Zhang WF, Xiong AZ, Wu WH, Zhu TT, Zou XZ, Liu T, Hu CP. microRNAs intergrates pathogenic signaling to control endothelial mesenchymal transition in pulmonary hypertension: results of a network bioinformatic approach. Zong Guo Yao Li Xue Tong Bao (Chinese Pharmacol Bulletin). 2016;32(9):1294\u2013300.","journal-title":"Zong Guo Yao Li Xue Tong Bao (Chinese Pharmacol Bulletin)"},{"issue":"1","key":"2895_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/FJC.0000000000001271","volume":"80","author":"H Cai","year":"2022","unstructured":"Cai H, Fan S, Cai L, Zhu L, Zhao Z, Li Y, Yao Y, Huang X, Wang L. Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2\/miR-503\/PI3K\/AKT axis. J Cardiovasc Pharmacol. 2022;80(1):95\u2013109.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"2895_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1535370216685434","volume":"242","author":"M Brock","year":"2017","unstructured":"Brock M, Schuoler C, Leuenberger C, Buhlmann C, Haider TJ, Vogel J, Ulrich S, Gassmann M, Kohler M, Huber LC. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation. Exp Biol Med (Maywood). 2017;242(5):487\u201396.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2895_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12864-021-08188-8","volume":"23","author":"H Wang","year":"2022","unstructured":"Wang H, Chen RB, Zhang SN, Zhang RF. N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis. BMC Genomics. 2022;23(1):33.","journal-title":"BMC Genomics"},{"issue":"3","key":"2895_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.14348\/molcells.2014.2308","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim J. Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension. Mol Cells. 2014;37(3):196\u2013201.","journal-title":"Mol Cells"},{"issue":"1","key":"2895_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12931-018-0956-z","volume":"19","author":"H Su","year":"2018","unstructured":"Su H, Xu X, Yan C, Shi Y, Hu Y, Dong L, Ying S, Ying K, Zhang R. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT(1)R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension. Respir Res. 2018;19(1):254.","journal-title":"Respir Res"},{"issue":"8","key":"2895_CR30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.7150\/ijbs.20316","volume":"13","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yuan T, Zhang H, Yan Y, Wang D, Fang L, Lu Y, Du G. Activation of Nrf2 attenuates pulmonary vascular remodeling via inhibiting endothelial-to-mesenchymal transition: an insight from a plant polyphenol. Int J Biol Sci. 2017;13(8):1067\u201381.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"2895_CR31","doi-asserted-by":"publisher","first-page":"19567","DOI":"10.1002\/jcb.29264","volume":"120","author":"J Wang","year":"2019","unstructured":"Wang J, Yan G, Guo H, Zhu Y, Shui X, He Y, Chen C, Lei W. ITE promotes hypoxia-induced transdifferentiation of human pulmonary arterial endothelial cells possibly by activating transforming growth factor-beta\/Smads and MAPK\/ERK pathways. J Cell Biochem. 2019;120(12):19567\u201377.","journal-title":"J Cell Biochem"},{"issue":"12","key":"2895_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/ars.2020.8169","volume":"34","author":"A Gorelova","year":"2021","unstructured":"Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal. 2021;34(12):891\u2013914.","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"2895_CR33","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1111\/jcmm.17318","volume":"26","author":"X Li","year":"2022","unstructured":"Li X, Zhang Y, Su L, Cai L, Zhang C, Zhang J, Sun J, Chai M, Cai M, Wu Q, Zhang C, Yan X, Wang L, Huang X. FGF21 alleviates pulmonary hypertension by inhibiting mTORC1\/EIF4EBP1 pathway via H19. J Cell Mol Med. 2022;26(10):3005\u201321.","journal-title":"J Cell Mol Med"},{"key":"2895_CR34","doi-asserted-by":"publisher","first-page":"586895","DOI":"10.3389\/fphar.2020.586895","volume":"11","author":"S Shi","year":"2020","unstructured":"Shi S, Song L, Yu H, Feng S, He J, Liu Y, He Y. Knockdown of LncRNA-H19 ameliorates kidney fibrosis in diabetic mice by suppressing miR-29a-mediated EndMT. Front Pharmacol. 2020;11:586895.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2895_CR35","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/jcp.30061","volume":"236","author":"C Li","year":"2021","unstructured":"Li C, Li Y, Zhuang M, Zhu B, Zhang W, Yan H, Zhang P, Li D, Yang J, Sun Y, Cui Q, Chen H, Jin P, Xia Z, Sun Y. Long noncoding RNA H19 act as a competing endogenous RNA of Let-7\u00a0g to facilitate IEC-6 cell migration and proliferation via regulating EGF. J Cell Physiol. 2021;236(4):2881\u201392.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2895_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/jcmm.12997","volume":"21","author":"PY Hsu","year":"2017","unstructured":"Hsu PY, Hsi E, Wang TM, Lin RT, Liao YC, Juo SH. MicroRNA let-7\u00a0g possesses a therapeutic potential for peripheral artery disease. J Cell Mol Med. 2017;21(3):519\u201329.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"2895_CR37","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3892\/or.2016.5098","volume":"36","author":"XH Zhang","year":"2016","unstructured":"Zhang XH, Qian Y, Li Z, Zhang NN, Xie YJ. Let-7\u00a0g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma. Oncol Rep. 2016;36(5):2967\u201375.","journal-title":"Oncol Rep"},{"key":"2895_CR38","doi-asserted-by":"crossref","unstructured":"Guo L, Yang Y, Liu J, Wang L, Li J, Wang Y, Liu Y, Gu S, Gan H, Cai J, Yuan JX, Wang J, Wang C. Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension. PLoS ONE. 2014;9(6):e101055.","DOI":"10.1371\/journal.pone.0101055"},{"key":"2895_CR39","doi-asserted-by":"crossref","unstructured":"Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, Cavalcanti-Adam EA, Blank KG, Knaus P. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFbeta responses and altered cell mechanics. PLoS Biol. 2019;17(12):e3000557.","DOI":"10.1371\/journal.pbio.3000557"},{"key":"2895_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ijbiomac.2021.11.098","volume":"194","author":"S Yuan","year":"2022","unstructured":"Yuan S, Dong M, Zhang H, Jiang X, Yan C, Ye R, Zhou H, Chen L, Lian H, Jin W. Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFbetaR1. Int J Biol Macromol. 2022;194:556\u201362.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2895_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1172\/JCI116967","volume":"93","author":"DK Kim","year":"1994","unstructured":"Kim DK, Zhang L, Dzau VJ, Pratt RE. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J Clin Invest. 1994;93(1):355\u201360.","journal-title":"J Clin Invest"},{"key":"2895_CR42","doi-asserted-by":"publisher","first-page":"45029","DOI":"10.1038\/srep45029","volume":"7","author":"W Wu","year":"2017","unstructured":"Wu W, Hu Q, Nie E, Yu T, Wu Y, Zhi T, Jiang K, Shen F, Wang Y, Zhang J, You Y. Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma. Sci Rep. 2017;7:45029.","journal-title":"Sci Rep"},{"issue":"4","key":"2895_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbamcr.2010.01.010","volume":"1803","author":"IJ Matouk","year":"2010","unstructured":"Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, Fellig Y, Degroot N, Galun E, Hochberg A. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta. 2010;1803(4):443\u201351.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2895_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.114.006977","volume":"131","author":"MR Wilkins","year":"2015","unstructured":"Wilkins MR, Ghofrani HA, Weissmann N, Aldashev A, Zhao L. Pathophysiology and treatment of high-altitude pulmonary vascular disease. Circulation. 2015;131(6):582\u201390.","journal-title":"Circulation"},{"issue":"3","key":"2895_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399\u2013408.","journal-title":"Cell"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02895-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T19:02:58Z","timestamp":1720638178000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2895"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02895-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted technology was not used in the preparation of the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}